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Aim To analyze the neurotoxic potential of synthesized 
magnetite nanoparticles coated by dextran, hydroxyeth-
yl starch, oxidized hydroxyethyl starch, and chitosan, and 
magnetic nanoparticles combined with ferritin as a native 
protein.
Methods The size of nanoparticles was analyzed using 
photon correlation spectroscopy, their effects on the con-
ductance of planar lipid membrane by planar lipid bilayer 
technique, membrane potential and acidification of syn-
aptic vesicles by spectrofluorimetry, and glutamate uptake 
and ambient level of glutamate in isolated rat brain nerve 
terminals (synaptosomes) by radiolabeled assay.
Results Uncoated synthesized magnetite nanoparticles 
and nanoparticles coated by different polysaccharides had 
no significant effect on synaptic vesicle acidification, the 
initial velocity of L-[14C]glutamate uptake, ambient level 
of L-[14C]glutamate and the potential of the plasma mem-
brane of synaptosomes, and conductance of planar lipid 
membrane. Native ferritin-based magnetic nanoparticles 
had no effect on the membrane potential but significantly 
reduced L-[14C]glutamate transport in synaptosomes and 
acidification of synaptic vesicles.
Conclusions Our study indicates that synthesized magne-
tite nanoparticles in contrast to ferritin have no effects on 
the functional state and glutamate transport of nerve ter-
minals, and so ferritin cannot be used as a prototype, ana-
logue, or model of polysaccharide-coated magnetic nano-
particle in toxicity risk assessment and manipulation of 
nerve terminals by external magnetic fields. Still, the ability 
of ferritin to change the functional state of nerve terminals 
in combination with its magnetic properties suggests its 
biotechnological potential.
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Superparamagnetic iron oxide nanoparticles are a promis-
ing candidate for increasing the efficiency of targeted drug 
delivery and therapy due to external magnetic guidance. 
Nanomaterials differ from those in bulk forms because 
they often show unexpected physical and chemical prop-
erties. They may produce potential functional and toxicity 
effects on human nerve cells due to their ability to pass 
through biological membranes and increase the risk of the 
development of neurodegenerative diseases (1-3). They 
can penetrate the blood-brain barrier (3-5) and kill nervous 
cells in vitro (6-8). Surface modification of iron oxide is a key 
issue for enhancing its interaction with the cell membrane. 
By using iron oxide nanoparticles coated by dextran, it was 
shown that labeled cells could be tracked by magnetic res-
onance imaging in vivo (9,10). Dextran occupies a special 
place among polysaccharides because of its wide applica-
tion. Contrast agents based on dextran-coated iron oxides, 
eg, Endorem (Guerbet, Roissy, France) and Resovist (Bay-
er Schering Pharma AG, Berlin-Wedding, Germany), have 
been commercially available for human use as blood pool 
agents. Similarly, immortalized cells from the MHP36 hip-
pocampal cell line labeled in vitro with gadolinium rhod-
amine dextran were tracked in ischemia-damaged rat hip-
pocampus in perfused brains ex vivo (11).
Taking into account that all nanoparticles are more or less 
toxic and the brain can be a target for their neurotoxic ac-
tion (3,8,12,13), it is crucial to know their neurotoxic poten-
tial. Estimation of neurotoxic risks of nanoparticles can be 
assessed at various levels of nervous system organization. 
This research was conducted at the neurochemical level 
according to the Guidelines for Neurotoxicity Risk Assess-
ment of US Environmental Protection Agency (14), assess-
ing the uptake and release of the neurotransmitters in 
nerve terminals (15,16). It has been suggested that a pos-
sible target for nanoparticles, beyond the already estab-
lished microglial cells, are presynaptic terminals of neurons 
(12). Presynaptic nerve terminals contain vesicular pool 
of neurotransmitters that can be released by exocytosis 
to the synaptic cleft in response to stimulation (17,18). A 
key excitatory neurotransmitter in the mammalian central 
nervous system is glutamate, which is implicated in many 
aspects of normal brain functioning. Abnormal glutamate 
homeostasis contributes to neuronal dysfunction and is in-
volved in the pathogenesis of major neurological disorders 
(19,20). Under normal physiological conditions, extracel-
lular glutamate between episodes of exocytotic release 
is kept at a low level, thereby preventing continual acti-
vation of glutamate receptors and protecting neurons 
from excitotoxic injury. Low extracellular glutamate 
concentration is maintained through its uptake by high-
affinity Na+-dependent glutamate transporters located in 
the plasma membrane of neurons and glial cells.
Prototypic nanoparticles have been shown to be useful 
for investigation of synaptic mechanisms underlying the 
development of neurotoxicity (8,12). Ferritin may be con-
sidered as a model nanoparticle (8,12) because it is com-
posed of 24 subunits, which form a spherical shell with a 
large cavity where up to 4500 ions Fe3+ can be deposited as 
compact mineral crystallites resembling ferrihydrite (21-25). 
Ferritin stores cellular iron in a dynamic manner allowing 
the release of the metal on demand (24). Its cores exhibit 
superparamagnetic properties, which are inherent to mag-
netic nanoparticles, and vary in diameter from 3.5 nm to 7.5 
nm in different tissues (26,27). This protein can penetrate 
blood-brain barrier (28) and be transported in different cells 
using clathrin-mediated endocytosis, similarly to many arti-
ficial nanoparticles that use the same mechanism (8,29,30).
Recently, there has started an examination of ferritin from 
the biotechnological point of view. The hypothesis was 
that ferritin might be considered a good tool and pro-
totypical nanoparticle for investigation of possible toxic 
properties of metal nanoparticles coated by dextran/poly-
mer shells and possible causes of neurodegeneration as-
sociated with exposure to nanoparticles (8,12). Ferritin has 
been suggested as a label for high-gradient magnetic sep-
aration (31) and magnetic force microscopy imaging (32). 
Recently, it has been shown that the avascular microscopic 
breast and brain tumors could be noninvasively detected 
by designing nanoparticles that contained human ferri-
tin as molecular probes for near-infrared fluorescence and 
magnetic resonance imaging (33).
This research was focused on two aspects – the first was the 
assessment of neurotoxic potential of synthesized nano-
particles of magnetite (MNP) coated by dextran, hydroxy-
ethyl starch, oxidized hydroxyethyl starch, chitosan as well 
as uncoated nanoparticles, studying their effects on: 1) the 
uptake of L-[14C]glutamate by rat brain nerve terminals via 
specific high-affinity Na+-dependent plasma membrane 
transporters; 2) the ambient level of L-[14C]glutamate in 
nerve terminals; 3) the membrane potential (Em) of the plas-
ma membrane of nerve terminals using potential-sensitive 
fluorescent dye Rhodamine 6G; 4) transmembrane current 
across the planar lipid membrane using planar lipid bilayer 
technique; 5) acidification of synaptic vesicles in nerve ter-
minals using pH-sensitive fluorescent dye acridine orange. 
The second aspect was a comparative analysis of neurotoxic 
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potential of these synthesized polysaccharide-coated nano-
particles and ferritin, which could bring new insight into a 
possible usage of ferritin as an analogue of polymer-coated 
magnetic nanoparticle in toxicity risk assessment.
MAteriALs ANd MethOds
Materials
Ethylene glycol tetraacetic acid (EGTA), 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), glucose, sucrose, 
Ficoll 400, and analytical grade salts were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Acridine orange and 
Rhodamine 6G were obtained from Molecular Probes (Eu-
gene, OR, USA) and L-[14C]glutamate and aqueous count-
ing scintillant (ACS) from Amersham (Little Chalfont, UK).
Wistar male rats, 100-120 g body weight, were obtained 
from the vivarium of MD Strazhesko Institute of Cardiology, 
Medical Academy of Sciences of Ukraine. Animals were kept 
in animal facilities of the Palladin Institute of Biochemistry in 
accordance with the European guidelines and international 
laws and policies (34). They were housed in a quiet, temper-
ature-controlled room (22-23°C) and were given water and 
dry food pellets ad libitum. Rats were decapitated and the 
brain was removed. Experimental protocols were approved 
by the Animal Care and Use Committee of the Palladin Insti-
tute of Biochemistry (Protocol from September 19, 2012).
synthesis of nanoparticles
MNP coated by dextran, hydroxyethyl starch, oxidized 
hydroxyethyl starch, chitosan as well as uncoated nano-
particles were synthesized at Semenenko Institute of 
Geochemistry, Mineralogy and Ore Formation, National 
Academy of Sciences of Ukraine in 2011. Fe3O4 nanoparti-
cles were obtained by hydrothermal precipitation of Fe2+ in 
aqueous medium in the presence of a weak oxidant in an 
oxygen-free atmosphere and coated by polysaccharides as 
described by Mykhaylyk et al (35).
Analysis of synthesized nanoparticles by dynamic light 
scattering
The MNP size was measured by dynamic light scattering 
with a laser correlation spectrometer ZetaSizer-3 (Malvern 
Instruments, Worcestershire, UK), equipped with He-Ne la-
ser LGN-111 (P = 25 mW, λ = 633 nm). The range of mea-
surements is from 1 nm to 50 µm. Suspension (1 mL) was 
placed in a cylindrical quartz cuvette, 10 mm in diameter, 
which was set into the laser correlation spectrometer. Reg-
istration and statistical processing of laser scattering of 
suspension of nanoparticles was performed repeatedly 
for 120 seconds at +22°С with scattering angle of 90°. The 
results were processed using computer software service 
PCS-Size mode v. 1.61 (Malvern Instruments). Laser corre-
lation spectrometer was equipped with multi computing 
correlator type 7032ce (Malvern Instruments).
Surface modification of iron oxide by biocompatible poly-
mers attached to surface of the nanoparticles prevented 
their agglomeration (36). MNP coated by dextran were as-
sessed using dynamic light scattering (Figure 1). The mea-
surements were performed in a standard salt solution, 
which contained (in mM) NaCl 126; KCl 5; MgCl2 2.0; NaH2-
PO4 1.0; HEPES 20, pH 7.4; and D-glucose 10. It was dem-
onstrated that suspension of MNP coated by this polysac-
charide (5 mg/mL) was stable and the average size of MNP 
varied between 50-70 nm. The results of dynamic light 
scattering analysis of MNP coated by hydroxyethyl starch, 
oxidized hydroxyethyl starch, and chitosan practically did 
not differ from those of MNP coated by dextran and thus 
were not shown.
isolation of rat brain nerve terminals (synaptosomes) 
and their interaction with nanoparticles
Cerebral hemispheres of decapitated animals were rapid-
ly removed and homogenized in ice-cold 0.32 M sucrose, 
5 mM HEPES-NaOH, pH 7.4, and 0.2 mM EDTA. The syn-
aptosomes were prepared by differential and Ficoll-400 
density gradient centrifugation of rat brain homogenate 
according to the method of Cotman (37) with slight modi-
Figure 1. dynamic light scattering histogram: assessment of the size of magne-
tite nanoparticles (5 mg/mL) coated by dextran in the standard salt solution. the 
measurements were performed in 2 minutes.
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fications (38-40). All manipulations were performed at 4°C. 
The synaptosomal suspensions were used in experiments 
during 2-4 hours after isolation. The standard salt solution 
was oxygenated. Ca2+-supplemented medium contained 2 
mM CaCl2, Ca
2+-free-1mM EGTA. Protein concentration was 
measured as described by Larson et al (41).
Recently, we have evaluated the average size of synapto-
somes using dynamic light scattering that was equal to 
3.24 ± 0.10 μm (16). In this study, interaction of synthesized 
polysaccharide-covered MNP and synaptosomes was ana-
lyzed. Using dynamic light scattering, it was demonstrated 
that the average size of synaptosomes (protein concentra-
tion of 0.5 mg/mL) was increased by ~ 20% in the presence 
of MNP coated by different polysaccharides (5 mg/mL).
L-[14C]glutamate uptake by synaptosomes
Synaptosomal suspension (125 μL; 0.2 mg of protein/mL) 
was pre-incubated in standard salt solution at 37°C for 8 
minutes, then nanoparticles were added to the synapto-
somal suspension and incubated for 10 minutes. Uptake 
was initiated by the addition of 10 µM L-glutamate sup-
plemented with 420 nM L-[14C]glutamate (0.1 µCi/mL), in-
cubated at 37°C during different time intervals (1, 2, 10 
minutes), and then rapidly sedimented using a microcen-
trifuge (20 seconds at 10 000 g). L-[14C]glutamate uptake 
was determined as a decrease in radioactivity in aliquots 
of the supernatant (100 μL) and an increase in radioactiv-
ity of sodium dodecyl sulfate-treated pellet, and was mea-
sured by liquid scintillation counting with ACS scintillation 
cocktail (1.5 mL).
In the analysis of the functional state of synaptosomes, 
we applied nanoparticles in a concentration of 2 mg/mL, 
which was much higher than used in toxicity assessment 
experiments for iron oxide or titanium oxide nanoparti-
cles (42,43).
L-[14C]glutamate release from synaptosomes
Synaptosomes were diluted in standard salt solution to 
reach the concentration of 2 mg of protein/mL and after 
pre-incubation at 37°C for 10 minutes they were loaded 
with L-[14C]glutamate (1 nmol/mg of protein, 238 mCi/
mmol) in Ca2+-supplemented oxygenated standard salt 
solution at 37°C for 10 minutes. After loading, the suspen-
sion was washed with 10 volumes of ice-cold oxygen-
ated standard salt solution; the pellet was resuspended 
in a solution to a final concentration of 1 mg pro-
tein/mL and immediately used for release experiments. 
Release of L-[14C]glutamate from the synaptosomes was 
performed in Ca2+-free incubation medium according to 
the following method: synaptosomal suspension (125 μL; 
0.5 mg of protein/mL) was pre-incubated for 10 minutes, 
then MNP (2 mg/mL) were added at 37°C and incubated 
for 5 minutes and rapidly sedimented using a microcentri-
fuge (20 seconds at 10 000 g). Release was measured in the 
aliquots of the supernatants (100 μL) by liquid scintillation 
counting with scintillation cocktail ACS (1.5 mL). Release 
of the neurotransmitter from synaptosomes incubated in 
Ca2+-free media without stimulating agents was used for 
the assay of unstimulated (tonic) release.
Measurement of synaptosomal plasma membrane 
potential (em)
Membrane potential was measured using Rhodamine 6G 
(0.5 µM), which bound with the plasma membrane. Mea-
surements were carried using a Hitachi MPF-4 (Tokyo, Ja-
pan) spectrofluorimeter at 528 nm (excitation) and 551 nm 
(emission) wavelengths (slit bands 5 nm each) (44). The 
suspension of synaptosomes (0.2 mg/mL of final protein 
concentration) preincubated at 37°C for 10 minutes was 
added to stirred thermostated cuvette. To estimate the 
changes in the plasma membrane potential, the ratio (F) 
as index of membrane potential was calculated according 
to Eq 1:
F = Ft /F0 (1)
where F0 and Ft are fluorescence intensities of a fluorescent 
dye in the absence and presence of the synaptosomes, re-
spectively. F0 was calculated by extrapolation of exponen-
tial decay function to t = 0. MNP or ferritin were added at 
the steady state level of the fluorescent signal.
Measurements of acidification of synaptosomes
Acridine orange, which is selectively accumulated by the 
acidic compartments of the synaptosomes (synaptic vesi-
cles), was used for monitoring synaptic vesicle acidification 
(45,46). Fluorescence changes were measured using a Hi-
tachi MPF-4 spectrofluorimeter at excitation and emission 
wavelengths of 490 and 530 nm, respectively (slit bands 
5 nm each). The reaction was started by the addition of 
acridine orange (final concentration 5 μM) to synaptosom-
al suspension (0.2 mg/mL of final protein concentration) 
preincubated in a stirred thermostated cuvette at 30°C for 
10 minutes. The equilibrium level of dye fluorescence was 
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achieved after 3 minutes. Fluorescence (F) was determined 
according to Eq. 1. MNP or ferritin were added at the steady 
state level of the fluorescent signal.
Analysis of the effect of synthesized nanoparticles on 
the conductance of planar lipid membrane
Planar lipid membrane (0.6 mm in diameter) was formed 
using the solution of phosphatidylcholine and cholester-
ol (2:1) in n-heptane, total amount of lipids consisted of 
20 mg/mL. Conductance of planar lipid membrane was 
assessed in a solution consisting of 100 mМ KCl and 10 
mM Tris-HCl pH 7.4, which was placed to the both cis- and 
trans-side of the membrane. Membrane potential was 
+100 mV. Experiments were carried out at room tempera-
ture (22-24°C) in a stirred cuvette. Final concentration of 
MNP was 0.1 mg/mL.
statistical analysis
Results are expressed as means ± standard error of the 
mean of n independent experiments. Difference between 
two groups was determined by two-tailed t-test. Differenc-
es were considered significant at Р≤0.05.
resuLts
the presence of synthesized nanoparticles of 
magnetite did not change membrane potential of 
nerve terminals
Glutamate transporters use Na+/K+ electrochemical gradi-
ents across the plasma membrane as a driving force, and 
so their functioning depends on the membrane potential 
(Em). The addition of synaptosomal suspension to the me-
dium containing Rhodamine 6G was accompanied by a 
partial decrease in fluorescence due to binding of the dye 
to the plasma membrane (Figure 2). Fst, the membrane po-
tential index at the steady state level, was achieved for 3 
minutes. Synthesized MNP did not influence the fluores-
cence signal of Rhodamine 6G (Figure 2), reflecting the ab-
sence of depolarization of the plasma membrane of nerve 
terminals.
the presence of synthesized nanoparticles of 
magnetite did not change conductance of planar lipid 
membrane
The data on the membrane potential of synaptosomes 
was confirmed by experiments using planar lipid bilayer 
conductance in the presence of synthesized MNP coat-
ed by dextran. After the addition of MNP (0.1 mg/mL) to 
cis-side of planar lipid membrane, the current across the 
membrane did not change considerably (Figure 3). These 
data are in agreement with the results of the assessment 
of the membrane potential in the presence of synthesized 
MNP. Uncoated synthesized MNP and MNP coated by hy-
droxyethyl starch, oxidized hydroxyethyl starch, and chito-
san also did not influence the conductance of planar lipid 
membrane (data not shown).
the presence of synthesized nanoparticles of 
magnetite did not change acidification of synaptic 
vesicles
After reaching the cytosol, the amino acid neurotransmit-
ters are accumulated in synaptic vesicles by specific ve-
Figure 2. Membrane potential of the synaptosomes after the 
addition of synthesized magnetite nanoparticles (MNP). the sus-
pension of the synaptosomes was equilibrated with potential-
sensitive dye rhodamine 6g (0.5 µM); when the steady level of 
the dye fluorescence had been reached, MNP (2 mg/mL) were 
added (arrows: 1 – uncoated MNP; 2 – MNP coated by dextran; 
3 – coated by hydroxyethyl starch; 4 – coated by oxidized hy-
droxyethyl starch; and 5 – coated  by chitosan). trace represents 
four experiments performed with different preparations.
Figure 3. Lack of the influence of synthesized magnetite 
nanoparticles (MNP) coated by dextran on the conductance of 
bilayer lipid membrane. MNP (arrow) were added from the cis-
side of membrane at a final concentration of 0.1 mg/mL.
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sicular transporters, which use the proton electrochemical 
gradient as a driving force. Using acridine orange, synaptic 
vesicle acidification was measured as an important compo-
nent of electrochemical proton gradient (∆μH
+). The addi-
tion of acridine orange to synaptosomes was accompanied 
by partial quenching of fluorescence signal due to dye ac-
cumulation in synaptic vesicles. After loading with acridine 
orange, synthesized MNP were added to synaptosomes at a 
concentration of 2 mg/mL. The addition of these nanopar-
ticles did not influence the fluorescence of acridine orange, 
indicating that synaptic vesicles retained appropriate pro-
ton gradient in the presence of MNP (Figure 4).
the presence of synthesized nanoparticles of 
magnetite did not change glutamate uptake and the 
extracellular level of glutamate in nerve terminals
Incubation of synthesized MNP coated by dextran with 
synaptosomes for 10 minutes did not cause significant 
changes in the initial velocity of high affinity Na+-depen-
dent L-[14C]glutamate uptake and accumulation of L-[14C]
glutamate (Figure 5). The initial velocity of L-[14C]gluta-
mate uptake by nerve terminals was equal to 2.5 ± 0.2 
nmol min-1 mg-1 protein in the control experiments and 
2.45 ± 0.2 nmol min-1 mg-1 protein in the presence of dex-
tran-coated MNP. Uncoated, hydroxyethyl starch-, oxidized 
hydroxyethyl starch-, and chitosan-coated MNP also did 
not influence the initial velocity of L-[14C]glutamate uptake 
and accumulation of L-[14C]glutamate by synaptosomes 
(data not shown).
In this set of the experiments, the extracellular level and 
tonic release of glutamate from nerve terminals in the 
presence of uncoated, and dextran-, hydroxyethyl starch-, 
oxidized hydroxyethyl starch-,and chitosan-coated MNP 
were analyzed. After 6 minutes of incubation, the extracel-
lular level of L-[14C]glutamate in synaptosomal suspension 
consisted of 204 ± 3 pmol of L-[14C]glutamate/mg of pro-
tein in the control experiment and insignificantly varied 
within the range of 5% in the presence of all types of syn-
thesized MNP. Therefore, we did not find significant chang-
es (P ≤ 0.10) in glutamate uptake and the extracellular level 
of glutamate in nerve terminals in the presence of synthe-
sized MNP.
Comparison of the neurotoxic potential of synthesized 
polysaccharide-coated nanoparticles of magnetite and 
native ferritin-based magnetic nanoparticles
We correlated the effects of synthesized polysaccharide-
coated MNP (dextran-coated nanoparticles at a concen-
tration of 2 mg/mL were used as an example) and ferri-
tin (100 μg/mL) on the initial velocity of L-[14C]glutamate 
uptake by synaptosomes (Figure 6A), the ambient level of 
L-[14C]glutamate (Figure 6B), synaptic vesicle acidification 
(Figure 6C), and the membrane potential (Figure 6D). Un-
coated, hydroxyethyl starch-, oxidized hydroxyethyl starch-, 
Figure 4. Acidification of synaptosomes in the presence of 
synthesized magnetite nanoparticles (MNP). the synaptosomes 
were equilibrated with acridine orange (5 µM); when the steady 
level of the dye fluorescence had been reached, MNP (2 mg/mL) 
were added (arrows: 1 – uncoated MNP; 2 – MNP coated by dex-
tran; 3 – coated by hydroxyethyl starch; 4 – coated by oxidized 
hydroxyethyl starch; and 5 – coated by chitosan). trace repre-
sents four experiments performed with different preparations.
Figure 5. time course of uptake of L-[14C]glutamate by control 
synaptosomes (solid line); synaptosomes in presence of dex-
tran-coated magnetite nanoparticles (MNP) (2 mg/mL) (dashed 
line). uptake was initiated by the addition of L-[14C]glutamate 
to synaptosomes, after incubation the samples were rapidly 
sedimented and radioactivity was determined as described in 
Materials and methods. data are presented as mean ± standard 
error of the mean of three independent experiments.
201Borysov et al: Neurotoxic potential of synthesized polysaccharide-coated and native ferritin-based magnetic nanoparticles
www.cmj.hr
and chitosan-coated MNP demonstrated similar effects as 
dextran-coated MNP. It was found that except the mem-
brane potential (Figure 6D), all other key characteristics of 
glutamatergic neurotransmission were changed as a result 
of ferritin application, ie, the initial velocity of L-[14C]gluta-
mate uptake was decreased (Figure 6A), the extracellular 
level of L-[14C]glutamate was increased in nerve terminals 
(Figure 6B), and the proton electrochemical gradient of 
synaptic vesicles was reduced, which indicates an increase 
in fluorescence of acridine orange (Figure 6C). Therefore, 
synthesized polysaccharide-coated MNP and native ferri-
tin-based magnetic nanoparticles differently influenced 
the functional state of nerve terminals.
disCussiON
Little is known about the involvement of excitotoxicity in 
nanoparticle-induced neuronal death (8,12). In this study, 
we assessed neurotoxic/excitotoxic potential of synthe-
sized MNP coated by dextran, hydroxyethyl starch, oxi-
dized hydroxyethyl starch, chitosan as well as uncoated 
MNP. It should be noted that dextran-coated iron oxides 
are widely used in biomedicine as supermagnetic agents 
for magnetic resonance imaging, for labeling of different 
cells and tissues, and transfection (9-11). Neurotoxicity risk 
assessment of synthesized and native nanoparticles was 
performed using isolated rat brain nerve terminals. Syn-
aptosomes retain all characteristics of intact nerve termi-
nals, that is, the ability to maintain membrane potential, 
accomplish glutamate uptake, exocytosis, etc. Synapto-
somes are one of the best systems to explore the relation-
ship between the structure of proteins, their biochemical 
and cell-biological properties, and physiological role (47). 
We demonstrated that synthesized polysaccharide-coated 
MNP did not influence the initial velocity of L-[14C]gluta-
mate uptake and the ambient level of L-[14C]glutamate in 
nerve terminals. It should be noted that a proper level of 
ambient glutamate is very important for synaptic transmis-
sion, whereas an increase in this level causes neurotoxicity. 
The ambient level of the neurotransmitter is determined 
by a balance between its uptake and tonic release from 
nerve terminals. Origin of tonic release is not complete-
ly identified. It is suggested that glutamate enriches the 
extracellular space by spontaneous exocytosis, swelling-
Figure 6. Comparison of the effects of synthesized magnetite nanoparticles (MNP) coated by dextran (2 mg/mL) (synthesized nano-
particle) and ferritin (100 μg/mL) (native nanoparticle) on the initial velocity of L-[14C]glutamate uptake by synaptosomes (A), the 
ambient level of L-[14C]glutamate at 5 minutes time point (B), synaptic vesicle acidification (C), and the membrane potential (D). data 
are presented as mean ± standard error of the mean of three independent experiments. *Р≤0.05 as compared to control.
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activated anion channels, cysteine-glutamate exchange, 
trans-membrane diffusion, and volume-sensitive Cl- chan-
nels (48). Acidification of synaptic vesicles, the membrane 
potential of nerve terminals and transmembrane current 
across the planar lipid membrane were not changed as a 
result of the application of these nanoparticles. Therefore, 
it was concluded from the in vitro study that synthesized 
polysaccharide-coated MNP did not change the functional 
state of nerve terminals.
Nanoparticles can be used in targeted drug delivery, as la-
bels in different diagnostics methods or scaffolding mate-
rials in neuronal regeneration (8,12,13) In experiments on 
mice, silica-coated cobalt ferrite nanoparticles were found 
in the brain after intravenous injection (49). Nanoparticles 
of TiO2 transferred from pregnant mice to their offspring 
can damage the genital and cranial nerve systems (50). Ac-
cording to one explanation, nanoparticles can be trans-
ported into the cells through endocytosis (51,52) and ac-
cording to another by diffusion or adhesive interactions 
(53). Olfactory mucosa and the olfactory bulb of rat brain 
could provide a portal for entry of intranasally instilled 
nanoparticles into the central nervous system circumvent-
ing the blood-brain barrier (54).
Recently, it has been hypothesized that ferritin could be a 
promising tool for assessment of possible toxic properties 
of metal nanoparticles coated by dextran/polymer and a 
good prototypical nanoparticle for investigation of proba-
ble causes of neurodegeneration associated with exposure 
to nanoparticles (8,12). Ferritin application can be support-
ed by several facts: 1) it consists of a hydrous ferric oxide 
phosphate particle coated by protein shell (21-25); 2) its 
cores exhibit superparamagnetic properties, which are in-
herent to magnetic nanoparticles (26); 3) ferritin can cross 
the blood-brain barrier like many nanoparticles (29); 4) fer-
ritin can be transported in different cells using clathrin-
mediated endocytosis similarly to many synthesized nano-
particles (8,29,30). In this study, we comparatively analyzed 
the neurotoxic potential of synthesized and native nano-
particles and demonstrated that in contrast to synthesized 
polysaccharide-coated MNP, ferritin significantly decreased 
the initial velocity of L-[14C]glutamate uptake by nerve ter-
minals, and as a consequence, increased the ambient lev-
el of L-[14C]glutamate in nerve terminals. Ferritin reduced 
the proton electrochemical gradient of synaptic vesicles, 
whereas synthesized MNP did not affect this parameter. It 
should be noted that ferritin-induced decrease in acidifi-
cation of synaptic vesicles may be one of the causes of 
weak glutamate uptake and enhanced extracellular 
level of glutamate in nerve terminals. We suppose that the 
observed effects of ferritin were not associated with the 
influence of exogenous iron ions. This is because release 
of iron ions from ferritin occurs mainly through lysosomal 
proteolysis and requires lysosomal activity (55). Therefore, 
synthesized and native nanopatrticles have diverse effects 
on the functional state of nerve terminals, whereas their 
similar feature was the absence of influence on the poten-
tial of the plasma membrane of nerve terminals.
The main limitation of this study was the difference in the 
size of synthesized polysaccharide-coated MNP, which var-
ied between 50-70 nm in a standard salt solution, and ferri-
tin molecule, whose core diameter was ~ 7.5 nm (26,27). This 
difference in inorganic core may be crucial for the process 
of interaction of synthesized and native nanoparticles with 
nerve terminals, which results in diverse functional effects 
on glutamate transport. However, we also used uncoated 
MNP subjected to sonication, the average diameter of which 
was ~ 10 nm (data not shown). The effects of these uncoated 
and polysaccharide-coated MNP on the key characteristics 
of glutamatergic neurotransmission were similar despite the 
difference in their size. Therefore, it can be suggested that 
the difference in the size of synthesized and native nanopar-
ticles was not a cause of the observed changes in the key 
characteristics of glutamatergic neurotransmission.
In conclusion, synthesized polysaccharide-coated MNP did 
not significantly influence the functional state of nerve ter-
minals and key characteristics of glutamatergic transmis-
sion, whereas native ferritin-based magnetic nanoparticles 
considerably affected the proton gradient and glutamate 
transport in nerve terminals. These data indicate that fer-
ritin could be used neither as a model/analogue of poly-
mer-coated magnetic nanoparticles in the assessment of 
their toxic properties and health risks during diagnostic la-
beling and manipulation by external magnetic fields, nor 
as a prototypical nanoparticle for investigation of possible 
causes of neurodegeneration associated with exposure to 
nanoparticles. Still, it could have a biotechnological poten-
tial due to its magnetic properties in combination with the 
ability to change the functional state of nerve terminals.
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